The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
Ask the Experts About

Nutrition and ExerciseNutrition and Exercise
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  • Email Email
  • Glossary Glossary

Cure possible?

Jan 21, 2011

I know you're following closely the developments for a possible HIV cure. I found the following website which focuses on the GcMAF approach.

GcMAF - treatment for cancer, aids and immune diseases Our immune system prevents and cures cancer

A macrophage (purple) eats cancer cellsThe first research was published in 1993 and since then many papers have appeared indicating GcMAF cured Cancer and eradicated HIV by simply activating the immune system.

Hundreds of scientists have worked on this and related projects, but studies are still only small scale and the researchers are not making GcMAF available to the public. The first and most visible researcher is Dr. Nobuto Yamamoto in Philadelphia USA.

How does GcMAF work?

In a healthy person macrophages in our bloodstream scour our bodies and kill malignancies; they get the message to go on the attack from Gc MAF, which is converted from Gc Protein. But malignant cells like cancer send out an enzyme called Nagalase that stops conversion of Gc protein to Gc MAF (Macrophage Activating Factor); so the macrophages never get the message to go into action in this way cancer suppresses the immune system, and cancer cells grow unchecked.

To reverse this we extract Gc Protein from blood; modify it outside the body to become the missing Gc-MAF, and inject it once a week for 25 weeks for early cancers, 50 or more weeks for late stage cancers. (Encapsulated tumours require additional treatment.) HIV can require as little as 16 weeks.

In its role of immune system regulator, GcMAF reverses other diseases that attack the immune system like Osteoporosis, Aids, Hodgkins, Lupus, MS, Fibromyalgia, Parkinsons, various bacterial and viral infections and various types of Immune dysfunction.

Small pre-clinical trials to build the case are again taking place.

Those diagnosed with any of these illnesses or who are otherwise convinced of the benefits of GcMAF for their health and who have done their own research on it are invited to respond. We ask for a copy of diagnostic information and update reports from a physician during and after treatments, to help build the case that GcMAF is a cure for various illnesses, which will help to make it available to the public. Participants are free to stop at any time.

What have we learned?

Dr Yamamoto carefully selected his trials: he took fit people with in the early stages of cancer, and reported 95-100% success. He did not attempt to cure people with large tumours.

Our trials are quite different: most people are over 50, some over 70, with long term and advanced cancers, with significant tumour mass.

We appear to have had stunning results in 20 percent of cases. But GcMAF does not work for everyone. It seems people fall into three categories: high, moderate and non responders to GcMAF. Tumours can shrink in volume by 50% by the 8th shot; if so you are a high responder. But there are some moderate responders with advanced cancers for whom GcMAF will not work on its own.

We have probably proved GcMAF can work for people up to age 67, with terminal stage 4 cancer, and can completely destroy large tumour mass in people of certain genotypes. See "Patients on GcMAF" on the left.

We have no success with bedridden or inactive people. Those patients who in 8 weeks are cured of symptoms, or whose tumour mass drops significantly, all take exercise, at least a 40 minute brisk walk each day. It seems the immune system doesn't wake up without exercise.

We seem to have better results than the group on "Yamamoto" GcMAF made in Israel, but that may be because of the genetic make up of their group, not because of their GcMAF.

We have specialised in stage 4 cancer but had two people with AIDS. GcMAF initially sent all their readings through the floor; it was quite frightening and we stopped supplying GcMAF to people with AIDS. It turned out there is a disease called IRIS (see "Research" top left) that attacks the immune system the moment it tries to repair itself. After nearly 10 weeks the GcMAF appears to have overcome that, and they have now made sufficiently good progress that they are about to become the subject of a published research article.

So we are now trying to find out how to make GcMAF work in serious cases for a wider group of people, and again, any help much appreciated.

We are now beginning new preclinical trials, and often have GcMAF available. See "Buy GcMAF here," top left. If you have questions, call our contact person Julian Williams on +44 7508 747 807, or click "Contact" at the top to send us an email.

What are your thoughts on this? What do you think about a possible breakthrough in the decade ahead?

Response from Mr. Vergel

This is a scam, so do not buy this product.

You may want to read the work that the AIDS Policy Project has summarized in this report: HIV eradication project

And read the section on immune based therapies that are in the pipeline in this great report from TAG:

TAG 2010 Pipeline Report

I am very excited that we are now using the word "Cure" in many of our activist discussions with researchers. It is not a four letter word anymore!


HIV Long Time Survivor
need to lose weight

  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS



This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint